Malignant gastrointestinal neuroectodermal tumor: clinicopathological analyses of four cases
10.3760/cma.j.cn112151-20191204-00780
- VernacularTitle:胃肠道恶性神经外胚层肿瘤四例临床病理学分析
- Author:
Haijian HUANG
1
;
Yihui HE
;
Dage FAN
;
Xiaoyan CHEN
Author Information
1. 福建医科大学省立临床医学院 福建省立医院病理科，福州 350001
- Keywords:
Gastrointestinal neoplasms;
Sarcoma, clear cell;
Neuroectodermal tumors, primitive;
Diagnosis, differential;
Immunohistochemistry;
Molecular diagnostic tec
- From:
Chinese Journal of Pathology
2020;49(8):821-826
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinicopathological features, diagnosis, differential diagnosis, and molecular alterations of malignant gastrointestinal neuroectodermal tumor (MGNET).Methods:Four cases of MGNET were collected at Fujian Provincial Hospital, from July 2013 to January 2019. H&E and immunohistochemical staining were retrospectively evaluated, together with genetic mutation analysis of EWSR1. The relevant literature was systematically reviewed.Results:There were two male and two female patients, with an age range of 34-81 (median 57) years. Tumor sizes ranged from 5-9 (median 6.8) cm. Microscopy showed diffuse and flaky growth of tumor cells, some of which were small and round. The tumor cells were arranged in solid, flaky, nested or pseudoadenoid patterns. The tumor cells were epithelioid, oval, short spindled, or small, with round or oval nuclei. The cytoplasm was eosinophilic or clear. Osteoclast-like multinucleated giant cells were scattered focally. Mitosis was about (2-10)/10 HPF. Immunohistochemically, the tumor cells were positive for S-100 protein (4/4), SOX10 (4/4), Syn (2/4), INI1 (4/4), H3K27Me3 (4/4) and vimentin (4/4). Ki-67 index was 15%-90%. Gene mutation detection confirmed EWSR1 mutation in all four cases, and C-KIT/PDGFRα genes were not mutated in two cases.Conclusions:MGNET is a rare high grade malignant soft tissue tumor. The diagnosis is based on clinicopathological, immunophenotypic, and molecular pathology features. The primary treatment for MGNET is complete surgical excision and chemotherapy; the prognosis is poor.
